SRC and neuroblastoma: Pyrazolo[3,4-d]pyrimidines have demonstrated a high anticancer activity associated to the inhibition of tyrosine kinases c-Src and Bcr-Abl and we have recently demonstrated that pyrazolo[3,4-d]pyrimidines were able to reduce tumor growth in NB xenograft mouse model25.